{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:49:57Z","timestamp":1670330997165},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDS"],"published-print":{"date-parts":[[2011,7,1]]},"DOI":"10.2174\/157488611797579285","type":"journal-article","created":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T15:56:58Z","timestamp":1317657418000},"page":"132-133","source":"Crossref","is-referenced-by-count":3,"title":["Editorial (Debating the Evidence: Oral Contraceptives Containing Drospirenone and Risk of Blood Clots)"],"prefix":"10.2174","volume":"6","author":[{"given":"Seetal","family":"Dodd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/75354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:25:12Z","timestamp":1448288712000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1574-8863&volume=6&issue=3&spage=132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/157488611797579285","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}